id | C00035822 |
---|---|
Name | Citral (E/Z) |
CAS RN | 5392-40-5 |
Standard InChI | InChI=1S/C10H16O/c1-9(2)5-4-6-10(3)7-8-11/h5,7-8H,4,6H2,1-3H3/b10-7+ |
Standard InChI (Main Layer) | InChI=1S/C10H16O/c1-9(2)5-4-6-10(3)7-8-11/h5,7-8H,4,6H2,1-3H3 |
Phytochemical cluster | No. 34 |
---|---|
KCF-S cluster | No. 1575 |
By standard InChI | CHEMBL1080997 |
---|---|
By standard InChI Main Layer | CHEMBL1080997 |
By LinkDB | C01499 |
---|
By CAS RN | C007076 |
---|
class name | count |
---|---|
Magnoliophyta | 2 |
Liliopsida | 1 |
rosids | 1 |
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Citrus limon | 2708 | Rutaceae | rosids | Viridiplantae |
Cymbopogon citratus | 66014 | Poaceae | Liliopsida | Viridiplantae |
Litsea cubeba | 155299 | Lauraceae | Magnoliophyta | Viridiplantae |
Litsea verbena | 22042 | Lauraceae | Magnoliophyta | Viridiplantae |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10828 | Thyroid hormone receptor beta | NR1A2 | CHEMBL1080997 |
CHEMBL1794399
(1)
|
3 / 1 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL1080997 |
CHEMBL1614458
(1)
|
0 / 0 |
O00519 | Fatty-acid amide hydrolase 1 | Enzyme | CHEMBL1080997 |
CHEMBL1099470
(1)
|
0 / 0 |
P10275 | Androgen receptor | NR3C4 | CHEMBL1080997 |
CHEMBL1794560
(1)
|
3 / 4 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | CHEMBL1080997 |
CHEMBL1613933
(1)
|
0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | CHEMBL1080997 |
CHEMBL1613933
(1)
|
1 / 6 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
C007076 | 1646 |
AKR1C2
AKR1C-pseudo BABP DD DD2 DDH2 HAKRD HBAB MCDR2 SRXY8 |
aldo-keto reductase family 1, member C2 (EC:1.3.1.20 1.1.1.357) | citral results in increased activity of AKR1C2 promoter |
increases activity
|
promoter |
21195160
|
C007076 | 1646 |
AKR1C2
AKR1C-pseudo BABP DD DD2 DDH2 HAKRD HBAB MCDR2 SRXY8 |
aldo-keto reductase family 1, member C2 (EC:1.3.1.20 1.1.1.357) | citral results in increased expression of AKR1C2 mRNA |
increases expression
|
mRNA |
20491607
|
C007076 | 1555 |
CYP2B6
CPB6 CYP2B CYP2B7 CYP2B7P CYPIIB6 EFVM IIB1 P450 |
cytochrome P450, family 2, subfamily B, polypeptide 6 (EC:1.14.14.1) | citral inhibits the reaction [CYP2B6 protein results in increased hydrolysis of Bupropion] |
decreases reaction
/ increases hydrolysis |
protein |
18611395
|
C007076 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | citral binds to ESR1 protein |
affects binding
|
protein |
12495555
|
C007076 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | citral inhibits the reaction [Estradiol binds to ESR1 protein] |
affects binding
/ decreases reaction |
protein |
12495555
|
C007076 | 2100 |
ESR2
ER-BETA ESR-BETA ESRB ESTRB Erb NR3A2 |
estrogen receptor 2 (ER beta) | citral binds to ESR2 protein |
affects binding
|
protein |
12495555
|
C007076 | 2100 |
ESR2
ER-BETA ESR-BETA ESRB ESTRB Erb NR3A2 |
estrogen receptor 2 (ER beta) | citral inhibits the reaction [Estradiol binds to ESR2 protein] |
affects binding
/ decreases reaction |
protein |
12495555
|
C007076 | 3162 |
HMOX1
HMOX1D HO-1 HSP32 bK286B10 |
heme oxygenase (decycling) 1 (EC:1.14.99.3) | citral results in increased expression of HMOX1 mRNA |
increases expression
|
mRNA |
20491607
|
C007076 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | Acetylcysteine inhibits the reaction [citral results in increased expression of IL8 mRNA] |
decreases reaction
/ increases expression |
mRNA |
21920952
|
C007076 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | citral results in increased expression of IL8 mRNA |
increases expression
|
mRNA |
21920952
|
C007076 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | citral results in increased secretion of IL8 protein |
increases secretion
|
protein |
20541004
|
C007076 | 23764 |
MAFF
U-MAF hMafF |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F | citral results in increased expression of MAFF mRNA |
increases expression
|
mRNA |
20491607
|
OMIM | preferred title | UniProt |
---|---|---|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
KEGG | disease name | UniProt |
---|---|---|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|